Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus, CKD and Albuminuria”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Study completedNCT00920764
What this trial is testing

Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 92
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878
What this trial is testing

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 64
Large-scale testing (Phase 3)Study completedNCT02547935
What this trial is testing

Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

Who this might be right for
Type 2 Diabetes Mellitus, CKD and Albuminuria
AstraZeneca 459
Not applicableLooking for participantsNCT05881447
What this trial is testing

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

Who this might be right for
Chronic Kidney DiseasesType 2 Diabetes MellitusArterial Hypertension+8 more
Swiss Tropical & Public Health Institute 1,200
Testing effectiveness (Phase 2)Study completedNCT00421733
What this trial is testing

The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
Abbott 281
Large-scale testing (Phase 3)Study completedNCT00552409
What this trial is testing

Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease

Who this might be right for
Diabetes MellitusChronic Kidney DiseaseDiabetic Kidney Disease
University of Washington 22
Not applicableActive Not RecruitingNCT07348718
What this trial is testing

Rubix LS Diabetic Kidney Disease (DKD) Registry Study

Who this might be right for
Diabetic Kidney Disease (DKD)
Rubix LS 2,000
Post-approval studies (Phase 4)Study completedNCT06374043
What this trial is testing

Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus Type 2 With ProteinuriaDiabetes Mellitus+7 more
University Medical Center Groningen 20
Testing effectiveness (Phase 2)Study completedNCT02358096
What this trial is testing

Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Astellas Pharma Europe B.V. 125
Not applicableNot Yet RecruitingNCT07605390
What this trial is testing

RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 600
Not applicableLooking for participantsNCT04916132
What this trial is testing

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

Who this might be right for
Chronic Kidney DiseasesAlbuminuriaDiabetic Kidney Disease+4 more
Herlev Hospital 300
Post-approval studies (Phase 4)Study completedNCT06094920
What this trial is testing

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

Who this might be right for
Diabetes Mellitus Type 2 With ProteinuriaDiabetes Mellitus, Type 2Diabetes Mellitus+10 more
University Medical Center Groningen 12
Testing effectiveness (Phase 2)Study completedNCT05570305
What this trial is testing

Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria

Who this might be right for
Chronic Kidney Diseases
University Medical Center Groningen 42
Testing effectiveness (Phase 2)Study completedNCT01356849
What this trial is testing

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 149
Early research (Phase 1)Study completedNCT01464320
What this trial is testing

Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.

Who this might be right for
Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine
Abbott 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07598864
What this trial is testing

"Dapagliflozin vs Dapagliflozin-Finerenone for Albuminuria in CKD With Type 2 Diabetes"

Who this might be right for
Diabetic Nephropathy
Chittagong Medical College 88
Testing effectiveness (Phase 2)Study completedNCT01847092
What this trial is testing

A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Ardelyx 154